US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Holdings

3,367.46

+35.821.08%

Number of Gainers:39

Number of Losers:34

Number of Flat:2

PE:- -

High:3,384.45

Open:3,331.63

Low:3,328.64

Close:3,331.64

Loading ...

Axsome Therapeutics Resolves Sunosi Patent Case With Hikma

MT Newswires Live

Foresight Ventures Demonstrate Leadership at ETH Denver with Strategic Engagements

Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline

Political Squabbling Cannot Slow TSMC’s Semiconductor Surge

Uxin Enters Agreement for $27.9 Million Investment From Fame Dragon Global

MT Newswires Live

Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Electric Vehicles Update - Electrifying Ford Fleet Solutions Drive Sustainability and Efficiency

Simply Wall St.

Why Uber Technologies, Inc. (NYSE:UBER) Could Be Worth Watching

Simply Wall St.

Axsome Therapeutics Inc - Hikma to Sell Generic Sunosi From Sept 2040 IF Pediatric Exclusivity Granted

THOMSON REUTERS

Axsome Therapeutics Settles Sunosi® (Solriamfetol) Patent Litigation With Hikma Pharmaceuticals USA

THOMSON REUTERS

Axsome Therapeutics Inc - Co and Hikma to Submit Settlement Agreement for FTC and DOJ Review

THOMSON REUTERS

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Hikma Pharmaceuticals USA

3 Strong Buy Profitable Stocks for March: NVMI, ACMR, UAL

Breakfast News: Trump Defends Tariffs

Trump Calls for End to $52 Billion CHIPS Act Subsidies

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4505/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4505"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4505\",,,,,undefined,":{"symbol":"BK4505","market":"US","secType":"PLATE","nameCN":"Hillhouse Capital Holdings","latestPrice":3367.455,"timestamp":1741381199999,"preClose":3331.6353,"halted":0,"volume":401001899,"delay":0,"changeRate":0.010751,"change":35.819824,"pbRate":9.286591,"amount":33416897803.29207,"amplitude":0.016753,"prevYearClose":3417.1636,"fiveDayClose":3397.7256,"twentyDayClose":3373.142,"turnoverRate":0.009996,"marketCap":6227247721404,"floatMarketCap":5861074843781.5,"peRate":31.005766},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4505\",,,,,undefined,":{"symbol":"BK4505","high":3384.4546,"amplitude":0.016753,"preClose":3331.6353,"low":3328.6396,"pbRate":"9.286591","latestPrice":3367.455,"volume":401001899,"delay":0,"open":3331.6328,"prevYearClose":3417.1636,"prevWeekClose":3367.455,"prevMonthClose":3397.7256,"prevQuarterClose":3417.1636,"fiveDayClose":3397.7256,"twentyDayClose":3373.142,"sixtyDayClose":3413.729,"secType":"PLATE","market":"US","turnoverRate":0.009996,"peRate":31.005766,"marketCap":6227247721404,"floatMarketCap":5861074843781.5,"timestamp":1741381199999,"nameCN":"Hillhouse Capital Holdings"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4505\",,,,undefined,":{"bkCode":"BK4505","up":39,"down":34,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4505\",pageSize:16,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517919070","title":"Axsome Therapeutics Resolves Sunosi Patent Case With Hikma","url":"https://stock-news.laohu8.com/highlight/detail?id=2517919070","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517919070?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:06","pubTimestamp":1741179964,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  said Wednesday it has reached a settlement with Hikma Pharmaceuticals resolving a patent dispute over its treatment Sunosi The dispute arose after Hikma filed an abbreviated new drug application seeking Food and Drug Administration approval to produce a generic version of Sunosi, the company said.As part of the agreement, Axsome said it will grant Hikma a license to launch its generic version no earlier than March 1, 2040, or Sept. 1, 2040, if pediatric exclusivity is granted, pending regulatory approval.Axsome said the settlement will be submitted for review by the US Federal Trade Commission and the Department of Justice.The company said similar patent litigation against other parties related to Sunosi remains pending in the US District Court for the District of New Jersey.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AXSM","BK4505","BK4585","BK4007"],"gpt_icon":0},{"id":"2517919103","title":"Foresight Ventures Demonstrate Leadership at ETH Denver with Strategic Engagements","url":"https://stock-news.laohu8.com/highlight/detail?id=2517919103","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517919103?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:00","pubTimestamp":1741179605,"startTime":"0","endTime":"0","summary":"Singapore, Singapore, March 5th, 2025, Chainwire Foresight Ventures, a global leading crypto investment firm with an aim of bridging east and west,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/foresight-ventures-demonstrate-leadership-at-eth-denver-with-strategic-engagements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/foresight-ventures-demonstrate-leadership-at-eth-denver-with-strategic-engagements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0006306889.USD","UBER","LU0642271901.SGD","LU1988902786.USD","LU0719512351.SGD","BK4588","SG9999015986.USD","LU1316542783.SGD","SG9999015978.USD","LU0082616367.USD","IE00BZ199S13.USD","SG9999018857.SGD","SGXZ31699556.SGD","SG9999018865.SGD","LU2087625088.SGD","IE0002270589.USD","LU0353189680.USD","LU0353189763.USD","BK4536","SG9999014914.USD","LU1064131342.USD","ETH","SG9999014906.USD","LU2360107325.USD","IE00B7SZLL34.SGD","GB00BDT5M118.USD","BK4230","SG9999015945.SGD","SG9999015952.SGD","LU1814569148.SGD","SG9999017495.SGD","BK4505","IE00B19Z3B42.SGD","LU2264538146.SGD","LU0127658192.USD","BK4503","BK4022","BK4551","LU1861219969.SGD","IE00B19Z3581.USD","LU0106261372.USD","LU1861214812.USD","LU1983260115.SGD","BK4601","BK4585","SG9999014880.SGD","BK4550","BK4535","SG9999014898.SGD"],"gpt_icon":0},{"id":"2517191079","title":"Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2517191079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517191079?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:50","pubTimestamp":1741179015,"startTime":"0","endTime":"0","summary":"An update from Olema Pharmaceuticals ( ($OLMA) ) is now available. On March 5, 2025, Olema Pharmaceuticals announced the availability of a presenta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/olema-pharmaceuticals-unveils-strategic-priorities-and-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/olema-pharmaceuticals-unveils-strategic-priorities-and-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OLMA","BK4505"],"gpt_icon":0},{"id":"2517916105","title":"Political Squabbling Cannot Slow TSMC’s Semiconductor Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916105","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916105?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:41","pubTimestamp":1741178483,"startTime":"0","endTime":"0","summary":"Taiwan Semiconductor Manufacturing Company ($TSM) makes a compelling investment case given its existing position as the world’s largest and most do...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/article/political-squabbling-cannot-slow-tsmcs-semiconductor-surge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/article/political-squabbling-cannot-slow-tsmcs-semiconductor-surge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BYQQ9H92.USD","LU0384037296.USD","LU1852331112.SGD","LU1282649810.SGD","LU2271345857.HKD","LU0719512351.SGD","03145","LU2471134796.USD","SG9999000418.SGD","LU0878004406.USD","LU2087625088.SGD","LU2491049909.HKD","LU0143863198.USD","IE0004086264.USD","LU0353189680.USD","LU1868837565.USD","LU1989772923.USD","LU2458330243.SGD","LU1989764664.SGD","BK4505","LU0541501648.USD","IE00BQXX3D17.EUR","LU0124676726.USD","BK4503","LU2663582299.SGD","LU0823414478.USD","LU2237443978.SGD","LU0109392836.USD","LU2237443549.SGD","BK4581","LU0541502299.USD","SGXZ51526630.SGD","TSM","LU0823421416.USD","IE0004445239.USD","LU2471134523.USD","LU2211815571.USD","BK4548","LU1989764748.USD","LU2237443382.USD","LU2491050154.USD","LU2506951792.HKD","BK4602","LU0056508442.USD","IE00B5TLWC47.USD","LU1623119135.USD","LU2133065610.SGD","LU0158827781.USD","LU2089283258.USD","LU0572940350.SGD"],"gpt_icon":0},{"id":"2517916128","title":"Uxin Enters Agreement for $27.9 Million Investment From Fame Dragon Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916128","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916128?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:39","pubTimestamp":1741178355,"startTime":"0","endTime":"0","summary":"Uxin  said Wednesday it entered into agreements with Fame Dragon Global, an investment vehicle of NIO Capital, to purchase 5.74 billion Class A shares for a total consideration of $27.9 million.The company said the agreements follow Fame Dragon Global's acquisition of NC Fund's rights and obligations under a previously announced binding term sheet from last March.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4122","UXIN","BK4214","BK4563"],"gpt_icon":0},{"id":"2517221916","title":"Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2517221916","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517221916?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:30","pubTimestamp":1741177800,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., March 05, 2025  -- Prelude Therapeutics Incorporated  , a clinical-stage precision oncology company, announced today that the Company will participate in the Barclays 27th Annual Global Healthcare Conference, taking place in Miami, FL on March 11, 2025.On Tuesday, March 11, 2025, at 12:30 p.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, Jane Huang, M.D., President and Chief Medical Officer, and Bryant Lim, Chief Financial Officer will participate in a fireside chat.Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline is comprised of several novel drug candidates including first-in-class, highly selective IV and oral SMARCA2 degraders, and a potentially best-in-class CDK9 inhibitor. We are also leveraging our expertise in targeted protein degradation to discover, develop and commercialize next generation degrader antibody conjugates  with partners. We ar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/prelude-therapeutics-participate-barclays-27th-123000555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4137","PRLD","BK4139","HCSG","BK4505"],"gpt_icon":0},{"id":"2517169699","title":"Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169699","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517169699?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:30","pubTimestamp":1741177800,"startTime":"0","endTime":"0","summary":"LONDON, March  05, 2025  (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/05/3037313/0/en/Mereo-BioPharma-to-Participate-in-Fireside-Chat-at-the-Leerink-Partners-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","BK4505","BK4139","BK4137","OI","MREO","BK4126"],"gpt_icon":0},{"id":"2517157989","title":"Electric Vehicles Update - Electrifying Ford Fleet Solutions Drive Sustainability and Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157989","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157989?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:07","pubTimestamp":1741176428,"startTime":"0","endTime":"0","summary":"BlueForce Energy has introduced innovative chassis-specific electrification solutions for the Ford F-Series, a key vehicle range for North American commercial fleets. This new development supports sustainability efforts by providing fleet operators with a cost-effective means to electrify their vehicles, offering significant reductions in emissions, fuel use, and maintenance costs. The electrification solutions are designed to maintain the renowned power and performance of the F-Series, with benefits including enhanced energy efficiency, lower operating costs, and improved environmental compliance. By making these solutions scalable and adaptable, BlueForce Energy aims to assist businesses and governments in achieving their sustainability and operational goals.Ford Motor last closed at $9.12 down 2.9%, close to the 52-week low.Elsewhere in the market, Delta Electronics  was trading firmly up 7.5% and ending trading at THB75.50. In the meantime, Continental softened, down 11.6% to end t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/electric-vehicles-electrifying-ford-fleet-120708194.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320764599.SGD","BK4555","BK4585","BK4509","BK4526","BK4516","LU0052750758.USD","F","BK4531","BK4505","BK4581","BK4534","BK4548","BK4588","BK4099","BK4574","NIO.SI","TSLA","EVS.SI","LU0708995583.HKD","NIO","BK4504","BK4532"],"gpt_icon":1},{"id":"2517915017","title":"Why Uber Technologies, Inc. (NYSE:UBER) Could Be Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2517915017","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517915017?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176018,"startTime":"0","endTime":"0","summary":"Uber Technologies, Inc.  saw a significant share price rise of 26% in the past couple of months on the NYSE. While good news for shareholders, the company has traded much higher in the past year. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. But what if there is still an opportunity to buy?Today we will analyse the most recent data on Uber Technologies’s outlook and valuation to see if the opportunity still exists.Check out our latest analysis for Uber Technologies. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. In terms of investment risks, we've identifi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-uber-technologies-inc-nyse-120018430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4230","SG9999015978.USD","SG9999014906.USD","LU1064131342.USD","BK4551","BK4022","BK4505","LU2087625088.SGD","LU2264538146.SGD","SG9999014914.USD","IE00B19Z3B42.SGD","SGXZ31699556.SGD","SG9999015952.SGD","LU0082616367.USD","SG9999015986.USD","LU0006306889.USD","LU0642271901.SGD","LU0719512351.SGD","LU0353189763.USD","LU1988902786.USD","SG9999018857.SGD","SG9999018865.SGD","BK4588","GB00BDT5M118.USD","IE00BZ199S13.USD","BK4535","SG9999014898.SGD","IE00B19Z3581.USD","BK4550","LU1861214812.USD","BK4536","SG9999015945.SGD","LU1983260115.SGD","LU0106261372.USD","LU1861219969.SGD","LU0353189680.USD","IE0002270589.USD","BK4585","NYSE","IE00B7SZLL34.SGD","LU1814569148.SGD","SG9999017495.SGD","SG9999014880.SGD","BK4503","LU0127658192.USD","UBER","LU1316542783.SGD","LU2360107325.USD"],"gpt_icon":0},{"id":"2517913676","title":"Axsome Therapeutics Inc - Hikma to Sell Generic Sunosi From Sept 2040 IF Pediatric Exclusivity Granted","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913676?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA5QTTLM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4585","BK4007","BK4505"],"gpt_icon":0},{"id":"2517691396","title":"Axsome Therapeutics Settles Sunosi® (Solriamfetol) Patent Litigation With Hikma Pharmaceuticals USA","url":"https://stock-news.laohu8.com/highlight/detail?id=2517691396","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517691396?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA5QTTLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4585","BK4505","AXSM"],"gpt_icon":0},{"id":"2517139539","title":"Axsome Therapeutics Inc - Co and Hikma to Submit Settlement Agreement for FTC and DOJ Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2517139539","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517139539?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA5QTTLM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","IE00B0JY6N72.USD","BK4007","BK4585","BK5011","HIK.UK","BK4505"],"gpt_icon":0},{"id":"2517913439","title":"Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Hikma Pharmaceuticals USA","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913439","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913439?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176000,"startTime":"0","endTime":"0","summary":"NEW YORK, March 05, 2025  -- Axsome Therapeutics, Inc.  , a biopharmaceutical company leading a new era in the treatment of central nervous system  disorders, today announced that it has entered into a settlement agreement with Hikma Pharmaceuticals USA, Inc.  resolving patent litigation related to Axsome’s product Sunosi . The litigation, which is pending in the United States District Court for the District of New Jersey, resulted from submission by Hikma of an Abbreviated New Drug Application to the U.S. Food and Drug Administration seeking approval to market a generic equivalent of Sunosi in the United States. Under the terms of the settlement agreement, Axsome will grant Hikma a license to sell its generic version of Sunosi beginning on or after September 1, 2040, if pediatric exclusivity is granted for Sunosi, or on or after March 1, 2040, if no pediatric exclusivity is granted, subject to FDA approval and conditions and exceptions customary for agreements of this type.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-therapeutics-settles-sunosi-solriamfetol-120000449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","BK4007","AXSM","BK4585","CNS","BK4135"],"gpt_icon":0},{"id":"2517912081","title":"3 Strong Buy Profitable Stocks for March: NVMI, ACMR, UAL","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912081","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517912081?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:55","pubTimestamp":1741175700,"startTime":"0","endTime":"0","summary":"Investors should prioritize profitable companies that generate solid returns after covering all costs rather than invest in those that operate at a loss.Here, we have used the concept of accounting ratios to evaluate a company’s profitability. There are several profitability ratios, from which we have chosen the most successful and frequently used profitability metric to determine a company's bottom-line performance.To that end, Nova Ltd. NVMI, ACM Research, Inc. ACMR and United Airlines Holdings, Inc. UAL have been selected as the top picks with a high net income ratio.The net income ratio is not the only indicator of future winners. So, we have added a few more criteria to arrive at a winning strategy.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-strong-buy-profitable-stocks-115500611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","BK4147","BK4008","BK4588","SG9999000418.SGD","UAL","BK4575","NVMI","ACMR","LU0278937759.USD","BK4585","BK4500"],"gpt_icon":0},{"id":"2517916577","title":"Breakfast News: Trump Defends Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916577","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916577?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:30","pubTimestamp":1741174200,"startTime":"0","endTime":"0","summary":"Stock market gives up post-election gains, chip subsidies under fire, Google breakup plans, and more...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/breakfast-news/2025/03/05/breakfast-news-trump-defends-tariffs/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0149725797.USD","LU1037948541.HKD","SG9999014542.SGD","LU0942090050.USD","BK4543","IE0005OL40V9.USD","LU1633808545.USD","IE00BWXC8680.SGD","LU0719512351.SGD","LU0234572021.USD","MACW.SI","LU2237443382.USD","LU1035773651.USD","LU2491049909.HKD","LU0289739343.SGD","LU2720916845.USD","LU1814569148.SGD","LU2505996681.GBP","LU0011850046.USD","BK4548","USJW.SI","LU2462157665.USD","LU1935042215.USD","GOOGL","LU0965509010.AUD","LU0308772762.SGD","BK4505","BK4587","LU0949170426.SGD","LU0077335932.USD","LU0965509283.SGD","LU2420271590.USD","LU0109391861.USD","IE00B3SWFQ91.USD","QCOM","IE0004091025.USD","LU2326559502.SGD","LU0097036916.USD","IE00BJTD4V19.USD","GOOG","LU0426412945.USD","LU2458330243.SGD","IE0009356076.USD","BK4507","LU0256863902.USD","LU1316542783.SGD","LU1934455863.HKD","LU1839511570.USD","LU0225283273.USD"],"gpt_icon":1},{"id":"2517699095","title":"Trump Calls for End to $52 Billion CHIPS Act Subsidies","url":"https://stock-news.laohu8.com/highlight/detail?id=2517699095","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517699095?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:17","pubTimestamp":1741173474,"startTime":"0","endTime":"0","summary":"President Donald Trump urged Congress to repeal the $52 billion CHIPS Act, calling it wasteful government spending, multiple outlets reported Wednesday, citing Trump's speech to Congress.Trump told House Speaker Mike Johnson to repeal the program and redirect any remaining funds toward debt reduction or other uses, media reports said.The legislation has prompted more than $400 billion in semiconductor investments, with the Biden administration recently approving more than $33 billion in subsidies, including up to $7.86 billion for Intel Corp. , $6.6 billion for Taiwan Semiconductor Manufacturing , and $6.1 billion for Micron Technology , as well as $4.75 billion for Samsung Electronics, these reports said.The CHIPS Act has bipartisan support, and many states benefit from chip manufacturing projects, according to these reports.Intel, TSMC, and Micron did not immediately respond to MT Newswires' request for comment.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B5TLWC47.USD","LU2271345857.HKD","IE0004086264.USD","LU0082616367.USD","MU","IE00BHPRN162.USD","LU0348723411.USD","LU0353189680.USD","LU0264606111.USD","BK4591","LU0321505439.SGD","BK4581","LU2458330243.SGD","SGXZ99366536.SGD","LU2106854487.HKD","LU0316494557.USD","LU0488056044.USD","TSM","LU0143863198.USD","BK4588","LU0109392836.USD","BK4533","LU0143863784.USD","LU0321505868.SGD","03145","LU2023251221.USD","BK4579","LU0823414551.USD","LU0719512351.SGD","LU2087625088.SGD","LU2458330169.SGD","BK4602","LU1852331112.SGD","BK4515","LU2089283258.USD","GB00BDT5M118.USD","LU1282649067.USD","IE00B19Z3581.USD","INTC","BK4505","BK4534","LU0353189763.USD","LU1508157978.USD","BK4605","LU2360032135.SGD","LU0882747503.HKD","LU2471134523.USD","BK4543","LU2471134952.CNY","LU2491050154.USD"],"gpt_icon":1}],"pageSize":16,"totalPage":55,"pageCount":12,"totalSize":869}]}}